NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Press Enter or click the Search button to begin your search.

Back to Results
Non-Pharmacological Countermeasure to Decrease Landing Sickness and Improve Functional PerformanceUpon return from long-duration spaceflight, 100% of crewmembers experience motion sickness (MS) symptoms. The interactions between crewmembers' adaptation to a gravitational transition, the performance decrements resulting from MS and/or use of promethazine (PMZ), and the constraints imposed by mission task demands could significantly challenge and limit an astronaut's ability to perform functional tasks during gravitational transitions. Stochastic resonance (SR) is "noise benefit": adding noise to a system might increase the information (examples to the left and above). Stochastic vestibular stimulation (SVS), or low levels of noise applied to the vestibular system, improves balance and locomotor performance (Goel et al. 2015, Mulavara et al. 2011, 2015). In hemi-lesioned rat models, Samoudi et al. 2012 found that SVS increased GABA release on the lesioned, but not the intact side. Activation of the GABA pathway is important in modulating MS and promoting adaptability (Cohen 2008) and was seen to reverse MS symptoms in rats after unilateral labyrinthectomy (Magnusson et al. 2000). Thus, SVS could be used to promote GABA pathways to reduce MS and promote adaptability, eliminate the need for PMZ or other performance-inhibiting drugs.
Document ID
20170000794
Acquisition Source
Johnson Space Center
Document Type
Presentation
Authors
Rosenberg, M. J. F.
(Baylor Coll. of Medicine Houston, TX, United States)
Kreutzberg, G. A.
(KBRwyle Science, Technology and Engineering Houston, TX, United States)
Galvan-Garza, R. C.
(Massachusetts Inst. of Tech. Cambridge, MA, United States)
Mulavara, A. P.
(KBRwyle Science, Technology and Engineering Houston, TX, United States)
Reschke, M. F.
(NASA Johnson Space Center Houston, TX, United States)
Date Acquired
January 25, 2017
Publication Date
January 23, 2017
Subject Category
Aerospace Medicine
Report/Patent Number
JSC-CN-38528
Report Number: JSC-CN-38528
Meeting Information
Meeting: 2017 NASA Human Research Program Investigators'' Workshop (HRP IWS 2017)
Location: Galveston, TX
Country: United States
Start Date: January 23, 2017
End Date: January 26, 2017
Sponsors: NASA Headquarters
Funding Number(s)
CONTRACT_GRANT: NCC9-58
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available